PTC Therapeutics (PTCT): Valuation Check After First Japan Approval Completes Global Sephience Launch [Yahoo! Finance]
PTC Therapeutics, Inc. (PTCT)
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ptcbio.com
Company Research
Source: Yahoo! Finance
This effectively rounds out a global launch after recent US, EU, and Canadian green lights. See our latest analysis for PTC Therapeutics. That global rollout narrative is showing up in the numbers, with the share price at $78.9 and a roughly 72 percent year to date share price return suggesting momentum is building, while the three year total shareholder return of about 116 percent points to meaningful long term wealth creation despite recent insider selling and mixed sentiment. If Sephience has you thinking more broadly about healthcare opportunities, this is a good moment to scan other ideas in healthcare stocks and see what else fits your strategy. With shares now hovering just below Wall Street's average target and growth investors cheering a global Sephience rollout despite negative earnings momentum, is PTC Therapeutics still mispriced or already discounting the next leg of expansion? With PTC Therapeutics last closing at $78.9 against a narrative fair value near $81.9
Show less
Read more
Impact Snapshot
Event Time:
PTCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTCT alerts
High impacting PTC Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PTCT
News
- Japan Sephience Approval Could Be A Game Changer For PTC Therapeutics' (PTCT) Rare-Disease Strategy [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in JapanPR Newswire
- ?????(TM)(???????)??????????(PKU)??????????????? [CNET News]CNET News
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR Newswire
PTCT
Earnings
- 11/4/25 - Beat
PTCT
Sec Filings
- 12/19/25 - Form 4
- 12/19/25 - Form 144
- 12/18/25 - Form 4
- PTCT's page on the SEC website